Treatment of Advanced Transitional Cell Carcinoma of the Bladder by Irinotecan in an Experimental Animal Model

Author(s):
Susanne LandsmannSusanne Landsmann1, Stephan SchwarzStephan Schwarz1, Thomas PapadopoulosThomas Papadopoulos1, Lothar HaeberleLothar Haeberle1, Dirk G. EngehausenDirk G. Engehausen1, Bernd WullichBernd Wullich1, Frens St. KrauseFrens St. Krause2,*
1Departement of Urology, University Clinic, Krankenhaustr. 12, 91054, Germany
2Departement of Urology, University Clinic, Krankenhaustr. 12, 91054, [email protected], Germany

Nephro-Urology Monthly:Vol. 2, issue 3; 447-454
Published online:Jul 31, 2010
Article type:Research Article
Received:Oct 08, 2009
Accepted:Nov 27, 2009
How to Cite:Landsmann S, Schwarz S, Papadopoulos T, Haeberle L, Engehausen D, et al. Treatment of Advanced Transitional Cell Carcinoma of the Bladder by Irinotecan in an Experimental Animal Model. Nephro-Urol Mon. 2010;2(3):. doi:

Abstract

Full Text

Full text is available in PDF

Similar Articles

30
Sep
2013

The Phase 2 Study of "(TOX) Preoperative Chemotherapy" Response Rate and Side Effects in [Locally Advanced Operable Gastric Adenocarcinoma] Patients With Docetaxel, Oxaliplatin and Capcitabine

Seyyed-Hossein Yahyazadeh-Jabbari,
Nasser Malekpour,
Bahram Salmanian,
Hossein Foodazi,
Masoud Salehi,
Farsad Noorizadeh

Yahyazadeh-Jabbari S, Malekpour N, Salmanian B, Foodazi H, Salehi M, et al. The Phase 2 Study of "(TOX) Preoperative Chemotherapy" Response Rate and Side Effects in [Locally Advanced Operable Gastric Adenocarcinoma] Patients With Docetaxel, Oxaliplatin and Capcitabine. Int J Cancer Manag. 2013;6(3):e80420. doi:

16
Jan
2016

Improving Compliance With a Single Post-Operative Dose of Intravesical Chemotherapy After Transurethral Resection of Bladder Tumour

Luke Stroman,
Ben Tschobotko,
Hamid Abboudi,
David Ellis,
Elsie Mensah,
Harikesh Kaneshayogan
,et al.

Stroman L, Tschobotko B, Abboudi H, Ellis D, Mensah E, et al. Improving Compliance With a Single Post-Operative Dose of Intravesical Chemotherapy After Transurethral Resection of Bladder Tumour. Nephro-Urol Mon. 2016;8(1):e29967. doi: https://doi.org/10.5812/numonthly.29967

31
Jan
2020

A Preliminary Study of NER and MMR Pathways Involved in Chemotherapy Response in Bladder Transitional Cell Carcinoma: Impact on progression-free survival

Vahideh Montazeri,
Mohammad Hossein Ghahremani,
Hamed Montazeri,
Mandana Hasanzad,
d, Majid Safavi,
Mohsen Ayati
,et al.

Montazeri V, Ghahremani MH, Montazeri H, Hasanzad M, Safavi DM, et al. A Preliminary Study of NER and MMR Pathways Involved in Chemotherapy Response in Bladder Transitional Cell Carcinoma: Impact on progression-free survival. Iran J Pharm Res. 2020;19(1):e124447. doi: https://doi.org/10.22037/ijpr.2020.112646.13878

17
May
2021
Nephro-Urol Mon

Comparison of Re-TUR Results in Primary Patients with Non-muscle-Invasive Bladder Cancer (NMIBC) of Low, Intermediate, and High-risk for Recurrence Based on the EORTC Scoring System

Farhood Khaleghi Mehr,
Pejman Shadpour,
Hossein Shahrokh,
Nima Narimani,
Maryam Abolhasani,
Mohsen Shati

Khaleghi Mehr F, Shadpour P, Shahrokh H, Narimani N, Abolhasani M, et al. Comparison of Re-TUR Results in Primary Patients with Non-muscle-Invasive Bladder Cancer (NMIBC) of Low, Intermediate, and High-risk for Recurrence Based on the EORTC Scoring System. Nephro-Urol Mon. 2021;13(2):e99800. doi: https://doi.org/10.5812/numonthly.99800

30
Apr
2017

Comparative Study Between Two Treatment Regimens of Cisplatin-5-Fluorouracil and Gemcitabine-Cisplatin in Gallbladder Cancer Patients

Daud Ali,
Nawazish Alam,
Farhat Yasmin,
Sajid Ali,
Tarique Anwer,
Sarfaraz Alam
,et al.

Ali D, Alam N, Yasmin F, Ali S, Anwer T, et al. Comparative Study Between Two Treatment Regimens of Cisplatin-5-Fluorouracil and Gemcitabine-Cisplatin in Gallbladder Cancer Patients. Iran J Pharm Res. 2017;16(2):e125015. doi: https://doi.org/10.22037/ijpr.2017.2038

Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles